Pentagastrin Solution

Pentagastrin Solution Recall

Get an alert when a recall is issued.

There is currently no warning information available for this product. We apologize for any inconvenience.

There is currently no legal information available for this drug.

There are currently no FDA safety alerts available for this drug.

There is currently no manufacturer warning information available for this drug.

There are currently no FDA labeling changes available for this drug.

Anacidity (diagnosis)—Pentagastrin is indicated as a diagnostic aid for evaluation of gastric acid secretory function. It is effective in testing for anacidity (achlorhydria) in patients with suspected pernicious anemia, atrophic gastritis, or gastric carcinoma. It is also effective in determining the reduction in acid output after operations for peptic ulcer, such as vagotomy or gastric resection.
Hypersecretory conditions, gastric (diagnosis)—Pentagastrin is indicated as a diagnostic aid in testing for gastric hypersecretion in patients with suspected duodenal ulcer or postoperative stomal ulcer, and for the diagnosis of Zollinger-Ellison tumor

There is currently no drug history available for this drug.

Pentagastrin, a diagnostic aid, is supplied as a sterile solution (1.1 ml/5 ml vial) containing:

Navigate to :

Anazaohealth Corporation
No Recall
Pentagastrin Solution | Anazaohealth Corporation
The intravenous infusion dose has ranged from 0.1 to 12 mcg (0.0001 to 0.012 mg) per kg of body weight per hour administered in a 0.9% sodium chloride injection. It can also be used as a subcutaneous injection for gastric function study with a dose of 6 mcg (0.006 mg) per kg of body weight.